Report of the Australian and New Zealand Neonatal Network 2001
Abstract
This is the 7th annual report of the Australian and New Zealand Neonatal Network and presents information on the network's 2001 annual audit of high risk neonates. All level III NICUs in Australia and New Zealand participate in the network's quality assurance measure. In 2001, 6805 babies were born who met the criteria for the Australian and New Zealand Neonatal Network’s (ANZNN) high-risk audit and were admitted to one of the 28 level III neonatal intensive care units (NICUs) throughout Australia and New Zealand. Of these, 3250 babies were born at less than 32 completed weeks gestation and 2791 were born weighing less than 1500 grams. Assisted ventilation (intermittent positive pressure ventilation (IPPV) and/or continuous positive airways pressure (CPAP) was given to a total of 5877 babies. There were 858 babies who received major surgery. Live births for both countries totalled 302193 in 2001 (Australian Bureau of Statistics, 2002; Statistics New Zealand, 2003). This is a decrease from the 313981 babies born in 1995. The ANZNN level III cohort now represents 2.25% of all live births in the two countries.
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.